Volitionrx limited says q3 cash and cash equivalents as of september 30, 2019 totaled $19.7 million

Volitionrx limited announces third quarter 2019 financial results and business update.volitionrx ltd - cash and cash equivalents as of september 30, 2019 totaled $19.7 million.

VNRX Ratings Summary

VNRX Quant Ranking